Magnetic resonance imaging and pathologic correlation in stage IB cervix cancers

Area of Science:

• Oncology
• Radiology
• Gynecologic Oncology

Background:

• Accurate staging of cervical carcinoma is crucial for effective treatment planning.
• Clinical examination, including examination under anesthesia (EUA), may underestimate tumor extent, particularly stromal invasion.
• Magnetic resonance imaging (MRI) offers advanced visualization capabilities for pelvic tumors.

Purpose of the Study:

• To evaluate the accuracy of magnetic resonance imaging (MRI) in assessing tumor volume and stromal invasion in Stage IB cervical carcinoma compared to clinical examination.
• To determine if MRI findings could have altered preoperative treatment selection.

Main Methods:

• Retrospective analysis of 10 patients with Stage IB cervical carcinoma.
• Comparison of preoperative magnetic resonance imaging (MRI) findings with examination under anesthesia (EUA) and subsequent pathological correlation.
• Assessment of tumor volume and stromal invasion by both methods.

Main Results:

• MRI correctly estimated tumor volume and stromal invasion in 9 out of 10 patients.
• Examination under anesthesia (EUA) frequently underestimated tumor extent, leading to delayed or potentially inappropriate treatment in 6 patients.
• Pathologic correlation confirmed MRI's superior accuracy in predicting tumor size and stromal involvement compared to clinical examination.

Conclusions:

• Magnetic resonance imaging (MRI) is a more accurate tool than clinical examination for evaluating tumor burden and stromal invasion in Stage IB cervical carcinoma.
• Preoperative MRI can significantly improve treatment planning, potentially guiding selection between primary surgery, radiation, or combined modalities.
• Incorporating MRI into the diagnostic pathway may optimize therapeutic strategies and patient outcomes for cervical cancer.